Role of chelates in magnetic resonance imaging studies

Journal of Cancer Research and Therapeutics

Volumn 5, Issue 3, 2009, Pages 148-153

  Tripathi, Laxmi ^a   Kumar, Praveen ^a   Singh, Ranjit ^b  

^a SD College of Pharmacy & Vocational Studies   (India)

^b SHOBHIT UNIVERSITY   (India)

Author keywords

Chelates; Magnetic resonance contrast media; Magnetic resonance imaging; Radioactive agents

Indexed keywords

B 21326; B 21327; BOMBESIN; CHELATE; CONTRAST MEDIUM; CYSTEINE ETHYL ESTER TC 99M; DOUBLE STRANDED DNA; EDETATE CHROMIUM; EUROPIUM CHELATE; FOLIC ACID INDIUM 111; GADOBENATE DIMEGLUMINE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE MEGLUMINE; GADOLINIUM POLYDISULFIDE COMPLEX; GADOLINUM PENTETATE CYSTINE BISAMIDE COPOLYMER; GOLD; INDIUM 111; IRON CHELATE; MONOCLONAL ANTIBODY; PENTETATE TECHNETIUM TC 99M; PEPTIDE BASED CHELATE; POLYGLUTAMIC ACID; SUPERPARAMAGNETIC IRON OXIDE; TECHNETIUM DERIVATIVE; TERBIUM CHELATE; UNCLASSIFIED DRUG;

BINDING AFFINITY; CANCER DIAGNOSIS; CHELATION; DIAGNOSTIC IMAGING; DNA DRUG COMPLEX; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; DRUG SPECIFICITY; DRUG STABILITY; DRUG TARGETING; KIDNEY FUNCTION; LIVER CELL CARCINOMA; MAGNETIC FIELD; MELANOMA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION EXPOSURE; RADIOFREQUENCY RADIATION; REVIEW; STRUCTURE ACTIVITY RELATION; TUMOR LOCALIZATION;

ANTIBODIES, MONOCLONAL; CHELATING AGENTS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DNA; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; RADIOPHARMACEUTICALS; TECHNETIUM;

EID: 70350331801     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.57118     Document Type: Review

References (48)

1. Frassica FJ, Khanna JA, McCarthy EF. The role of MR imaging in soft tissue tumor evaluation:perspective of the orthopedic oncologist and musculoskeletal pathologist. Magn Reson Imaging Clin N Am 2000;8:915-927
2. Hopper KD, Singapuri K, Finkel A. Body CT and oncologic imaging. Radiology 2000;215:27-40.
3. Pomper MG, Port JD. New techniques in MR imaging of brain tumors. Magn Reson Imaging Clin N Am 2000;8:691-713.
4. Cotton FA, Wilkinson G, Murillo CA. Advanced Inorganic Chemistry. Manfred Bochmann: VII, 2003. p. 32-33
5. Kumar V, Cotran RS, Robbins SL, Saunder- An Imprint of Elsevier Science; VII 2003. p. 197-198
6. Schneider G, Uder M. Contrast-enhanced magnetic resonance body imaging 5. Top Magn Reson Imaging 2003;14:403-425 (Pubitemid 37521731)
7. Banerjee S, Pillai MR, Ramamoorthy N. Evolution of Tc-99m in diagnostic radiopharmaceuticals. Semin Nucl Med 2001;31:260-277
8. Cheng Z, Mahmood A, Li H, Davison A, Jones AG. [99mTcOAADT]- (CH2) 2-NEt2: a potential small-molecule single-photon emission computed tomography probe for imaging metastatic melanoma. Cancer Res 2005;65:4979-4986
9. Friebe M, Mahmood A, Bolzati C, Drews A, Johannsen B, Eisenhut M, et al. [99mTc]oxotechnetium(V) complexes amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma. J Med Chem 2001;44:3132-3140
10. Tombach B, Heindel W. Value of 1.0M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol 2002;12:1550-1556
11. Cavagna FM, Maggioni F, Castelli PM, Daprà M, Imperatori LG, Lorusso V, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796
12. Lu ZR, Mohs AM, Zong Y, Feng Y. Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents. Int J Nanomedicine 2006;1:31-40.
13. Ke T, Feng Y, Guo J, Parker DL, Lu ZR. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd- DO3A conjugates for contrast-enhanced MR imaging. Magn Reson Imaging 2006;24:931-940
14. Kaneshiro TL, Ke T, Jeong EK, Parker DL, Lu ZR. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging. Pharm Res 2006;23:1285-1294
15. Low RN. MR imaging of the liver using gadolinium chelates. Magn Reson Imaging Clin N Am 2001;9:717-743
16. Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR contrast agents for liver imaging: what, when, how. Radiographics 2006;26:1621-1636
17. Voisin P, Ribot EJ, Miraux S, Bouzier-Sore AK, Lahitte JF, Bouchaud V, et al. Use of lanthanide-grafted inorganic nanoparticles as effective contrast agents for cellular uptake imaging. Bioconjug Chem 2007;18:1053-1063
18. Low RN. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver. Top Magn Reson Imaging 1998; 9:141-166
19. Imam K, Bluemke DA. MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin N Am 2000;8:741-756
20. Bradley WG. Use of contrast in MR imaging of the lumbar spine. Magn Reson Imaging Clin N Am 1999;7:439-457
21. Marzola P, Ramponi S, Nicolato E, Lovati E, Sandri M, Calderan L, et al. Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents. Invest Radiol 2005; 40:421-429
22. Luciani A, Dao TH, Lapeyre M, Schwarzinger M, Debaecque C, Lantieri L, et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. AJR Am J Roentgenol 2004;182:1059-1067
23. Padhani AR, Dzik-Jurasz A. Perfusion MR imaging of extracranial tumor angiogenesis. Top Magn Reson Imaging 2004;15:41-57.
24. Hasso AN, Brown KD. Use of gadolinium chelates in MR imaging of lesions of the extracranial head and neck. J Magn Reson Imaging 1993;3:247-263
25. Griffiths PD, Wilkinson ID, Wels T, Hoggard N. Brain MR perfusion imaging in humans. Acta Radiol 2001;42:555-559
26. Zhang T, Matsumura A, Yamamoto T, Yoshida F, Nose T, Shimojo N. Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors. AJNR Am J Neuroradiol 2002;23:15-18
27. Kettritz U, Semelka RC. Contrast-enhanced MR imaging of the pancreas. Magn Reson Imaging Clin N Am 1996;4:87-100.
28. Kidney DD, Dietrich RB, Goyal AK, Yan K, Bradley WG Jr. MRI of extracranial masses in children: the usefulness of gadolinium-chelate enhancement. Pediatr Radiol 1998;28:322-328
29. Yan GP, Liu ML, Li LY. Polyaspartamide gadolinium complexes containing sulfadiazine groups as potential macromolecular MRI contrast agents. Bioconjug Chem 2005;16:967-971
30. Ward J, Robinson PJ. Combined use of MR contrast agents for evaluating liver disease. Magn Reson Imaging Clin N Am 2001;9:767-802.
31. Kubaska S, Sahani DV, Saini S, Hahn PF, Halpern E. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Clin Radiol 2001;56:410-415
32. Alonzi R., Padhani AR., Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 2007;63:335-350
33. Bornhop DJ, Griffin JM, Goebel TS, Sudduth MR, Bell B, Motamedi M. Luminescent lanthanide chelate contrast agents and detection of lesions in the hamster oral cancer model. Appl Spectrosc 2003;57:1216-1222
34. Sardanelli F, Iozzelli A, Fausto A. Contrast agents and temporal resolution in breast MR imaging. J Exp Clin Cancer Res 2002;21:69-75.
35. Runge VM, Foster MA, Clanton JA, Jones MM, Lukehart CM, Hutchison JM, et al. Contrast enhancement of magnetic resonance images by chromium EDTA: an experimental study. Radiology 1984;152:123-126
36. Carr DH. The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies. Physiol Chem Phys Med NMR 1984;16:137-144
37. Sevéus L, Väisälä M, Hemmilä I, Kojola H, Roomans GM, Soini E. Use of fluorescent europium chelates as labels in microscopy allows glutaraldehyde fixation and permanent mounting and leads to reduced autofluorescence and good long-term stability. Microsc Res Tech 1994;28:149-154
38. Artemov D. Molecular magnetic resonance imaging with targeted contrast agents. J Cell Biochem 2003;90:518-524 (Pubitemid 37243699)
39. Scheinberg DA, Strand M, Gansow OA. Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science 1982;215:1511-1513
40. Kranenborg MH, Boerman OC, Oosterwijk-Wakka JC, de Weijert MC, Corstens FH, Oosterwijk E. Two-step radioimmunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal- Author Help: Reference checking facility cell-carcinoma X anti-DTPA bispecific monoclonal antibodies. Int J Cancer 1998;75:74-80.
41. Roselli M, Schlom J, Gansow OA, Brechbiel MW, Mirzadeh S, Pippin CG, et al. Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies. Int J Rad Appl Instrum B 1991;18:389-394
42. Hnatowich DJ. Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium. Semin Nucl Med 1990;20:80-91.
43. Ke CY, Mathias CJ, Green MA. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid. J Am Chem Soc 2005;127:7421-7426
44. Haseman MK, Goodwin DA, Meares CF, Kaminski MS, Wensel TG, McCall MJ, et al. Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice. Eur J Nucl Med 1986;12:455-460
45. Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, et al. In-vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res 2000;60:5237-5243
46. Goodwin DA., Meares CF., David GF., McTigue M., McCall MJ., Frincke JM. Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals. Int J Rad Appl Instrum B 1986;13:383-391
47. Väisänen V, Härmä H, Lilja H, Bjartell A. Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticlesa conjugated to monoclonal antibodies. Luminescence 2000;15:389-397
48. Bogdanov A Jr, Tung CH, Bredow S, Weissleder R. DNA binding chelates for nonviral gene delivery imaging. Gene Ther 2001;8:515-522